Cardinal Health, Inc. $CAH Shares Sold by Triad Wealth Partners LLC

Triad Wealth Partners LLC trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,553 shares of the company’s stock after selling 118 shares during the quarter. Triad Wealth Partners LLC’s holdings in Cardinal Health were worth $261,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Principal Financial Group Inc. grew its stake in Cardinal Health by 5.3% in the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock valued at $43,510,000 after acquiring an additional 15,956 shares during the last quarter. Kingswood Wealth Advisors LLC grew its position in shares of Cardinal Health by 17.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company’s stock valued at $429,000 after purchasing an additional 457 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in shares of Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company’s stock worth $1,811,000 after purchasing an additional 2,694 shares in the last quarter. Golden State Wealth Management LLC increased its stake in shares of Cardinal Health by 569.5% during the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock worth $54,000 after purchasing an additional 336 shares in the last quarter. Finally, North Capital Inc. acquired a new position in shares of Cardinal Health during the 1st quarter worth approximately $83,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH stock opened at $154.50 on Friday. The firm’s 50-day simple moving average is $152.07 and its 200-day simple moving average is $150.25. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The firm has a market cap of $36.71 billion, a P/E ratio of 23.95, a PEG ratio of 1.34 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on CAH shares. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday, August 12th. UBS Group reiterated a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Robert W. Baird lifted their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a report on Wednesday, August 13th. Finally, Evercore ISI reduced their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $165.93.

Insider Buying and Selling

In other Cardinal Health news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider directly owned 14,976 shares of the company’s stock, valued at $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.